

Cartesian Therapeutics: Detailed Company Information & Corporate Profile
Summary
Cartesian Therapeutics is a biotechnology company headquartered in Frederick, Maryland, founded in 2016 with an employee base of 100‑200 and annual revenue between $1 and $10 million.
Its research portfolio centers on immunotherapy and oncology, encompassing molecular biology, immunology, and cell therapy. Key therapeutic areas include myasthenia gravis, acute respiratory distress syndrome (ARDS), neuroendocrine tumors (NETs), multiple myeloma, systemic lupus erythematosus (SLE), and other autoimmune diseases. The company also advances gene therapy, mRNA platforms, CAR‑T cells, and bispecific antibody development for autoimmunity and cancer.
Leadership is driven by President & CEO Carsten Brunn, with Vice Presidents John Higgins (Technical Operations) and Volkan Granit (Clinical Development), alongside heads of Commercial (Kelli Tea), Process Sciences (Alex Torres), Launch Program Management (Lisa Grant), and Information Technology (Kate Sorensen). The scientific team includes Senior Scientist Juliana Ferreira de Sousa, Director Mehmet, and Principal Scientist Celine Walmacq.
| Cartesian Therapeutics Website | cartesiantherapeutics.com |
| Industries | |
| Cartesian Therapeutics Headquarters Address | 7495 New Horizon Way, Frederick, Maryland, 21703 US |
| Company Size | 100-200 employees |
| Specialities & Services | Immunotherapy, Oncology, Molecular Biology, Immunology, Myasthenia Gravis, ARDS, Cell Therapy, NETs, Gene Therapy, Cancer Research, multiple myeloma, SLE, mRNA, CAR-T, Systemic lupus erythematosus, Autoimmunity, Autoimmune Disease, Lupus |
| Founded | 2016 |
| Estimated Annual Revenue | $1 - 10M |
| Updated: | 2026-09-18 |
Cartesian Therapeutics Org Chart
Chief Executive Officer
C-Level
Estimated Website Traffic
The chart shows a growth in traffic to the cartesiantherapeutics.com website. In September, traffic increased to 9920, compared to 2623 in the previous month. The highest traffic in 2026 was recorded in September, reaching 9920 visits.
Workforce Turnover
Number of employees switched from or switched to
Departmental sample breakdown
Length of Employment
Cartesian Therapeutics's workforce includes employees across a wide range of tenure levels.
13% have been with the company for less than 1 year25% have been with the company for 1 to 2 years25% have been with the company for 3 to 4 years25% have been with the company for 5 to 7 years13% have been with the company for more than 11 yearsCompanies Similar to Cartesian Therapeutics
Cartesian Therapeutics Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.





